Kojin Therapeutics
1 follower
‌
Kojin is pioneering cell-state and ferroptosis biology and cutting-edge drug discovery to develop first-in-class small-molecule treatments that modulate ferroptosis.
Industries
Headquarters
Employees
Links
Org chart
Harvey J. Berger
Chairman, Chief Executive Officer & President
Harvey J. Berger
Collapse
Horst Hemmerle
SVP & Chief Scientific Officer
David Dalgarno
SVP, Digital & Data Science and Technology
Wei-Sheng Huang
SVP, Drug Discovery
Narayana Narasimhan
SVP, Preclinical Safety and DMPK
